Clincosm LogoSign in Get a demo

Human Immunodeficiency Virus

Showing 51 - 75 of 281
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Immunodeficiency Virus Trial in Vancouver (Dance Program)

Recruiting
  • Human Immunodeficiency Virus
  • Dance Program
  • Vancouver, British Columbia, Canada
    University of British Columbia
May 16, 2022

Human Immunodeficiency Virus Trial in Birmingham, Philadelphia, Pittsburgh (Client-Centered Representative Payee)

Active, not recruiting
  • Human Immunodeficiency Virus
  • Client-Centered Representative Payee
  • Birmingham, Alabama
  • +2 more
May 8, 2022

Human Immunodeficiency Virus Trial in Newark (Dolutegravir/Lamivudine)

Active, not recruiting
  • Human Immunodeficiency Virus
  • Newark, New Jersey
    Saint Michael's Medical Center
May 3, 2022

Human Immunodeficiency Virus Trial in Milwaukee (IMB)

Not yet recruiting
  • Human Immunodeficiency Virus
  • IMB
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Apr 29, 2022

Human Immunodeficiency Virus Trial in Sweetwaters (A couples-focused intervention for HIV prevention and care in South Africa)

Recruiting
  • Human Immunodeficiency Virus
  • A couples-focused intervention for HIV prevention and care in South Africa
  • Sweetwaters, KwaZulu Natal, South Africa
    Human Sciences Research Council
May 3, 2022

Entry and Continuation in Care for People Living With HIV in

Recruiting
  • Human Immunodeficiency Virus
  • quetionnaire
  • Cayenne, France, French Guiana
    Centre Hospitalier de Cayenne
Apr 28, 2022

Human Immunodeficiency Virus Trial in Balaka, Machinga (Enhanced implementation package, Standard implementation package)

Recruiting
  • Human Immunodeficiency Virus
  • Enhanced implementation package
  • Standard implementation package
  • Balaka, Malawi
  • +32 more
Apr 18, 2022

Human Immunodeficiency Virus Trial in Pebane (Couples-based services)

Active, not recruiting
  • Human Immunodeficiency Virus
  • Couples-based services
  • Pebane, Zambezia, Mozambique
    Minisitry of Health Health Facility
Apr 1, 2022

Human Immunodeficiency Virus Trial (BIKTARVY 50Mg-200Mg-25Mg Tablet)

Not yet recruiting
  • Human Immunodeficiency Virus
  • BIKTARVY 50Mg-200Mg-25Mg Tablet
  • (no location specified)
Mar 31, 2022

Contributing Factors for Poor HIV Treatment Response in TB/HIV

Recruiting
  • Tuberculosis
  • +2 more
  • Observational study
  • Kumasi, Ghana
    Kwame Nkrumah University of Science and Technology
Mar 23, 2022

HIV, Human Immunodeficiency Virus Trial in Salt Lake City (Euphorbia kansui extract powder prepared as tea)

Suspended
  • HIV
  • Human Immunodeficiency Virus
  • Euphorbia kansui extract powder prepared as tea
  • Salt Lake City, Utah
    University of Utah
Mar 22, 2022

Human Immunodeficiency Virus, Contraception, ART Trial in Gaborone (Dolutegravir, Levonorgestrel implant, Depo

Recruiting
  • Human Immunodeficiency Virus
  • +2 more
  • Gaborone, Botswana
    Princess Marina Hospital
Mar 1, 2022

Human Immunodeficiency Virus Trial in South Africa (M72/AS01E Mycobacterium tuberculosis vaccine, Placebo)

Active, not recruiting
  • Human Immunodeficiency Virus
  • M72/AS01E Mycobacterium tuberculosis vaccine
  • Placebo
  • Johannesburg, Gauteng, South Africa
  • +5 more
Feb 26, 2022

Human Immunodeficiency Virus, HIV Seropositivity Trial in Atlanta, Philadelphia (iTransition)

Recruiting
  • Human Immunodeficiency Virus
  • HIV Seropositivity
  • iTransition
  • Atlanta, Georgia
  • +2 more
Mar 9, 2022

Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

Completed
Has Results
  • Human Immunodeficiency Virus
  • Ad26.Mos.HIV
  • +2 more
  • Bangkok, Thailand
    (unnamed)
Dec 29, 2021

Human Immunodeficiency Virus Trial in Nairobi (Home visits, HIV Self-testing)

Recruiting
  • Human Immunodeficiency Virus
  • Home visits
  • HIV Self-testing
  • Nairobi, Kenya
    Kenya Medical Research Institute
Mar 8, 2022

Human Immunodeficiency Virus Trial in Aurora

Completed
  • Human Immunodeficiency Virus
    • Aurora, Colorado
      University of Colorado, Denver
    Mar 4, 2022

    Papillomavirus Vaccines, Human Immunodeficiency Virus, Papillomavirus Infection Trial in New Orleans (Human papillomavirus

    Not yet recruiting
    • Papillomavirus Vaccines
    • +6 more
    • Human papillomavirus 9-valent vaccine, recombinant
    • New Orleans, Louisiana
      University Medical Center New Orleans
    Mar 3, 2022

    Human Immunodeficiency Virus, Depression, Anxiety Trial in Houston (THRIVE, Treatment as Usual)

    Enrolling by invitation
    • Human Immunodeficiency Virus
    • +2 more
    • THRIVE
    • Treatment as Usual
    • Houston, Texas
      Ben Taub Hospital
    Feb 28, 2022

    HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV

    Recruiting
    • Cervical Cancer
    • +3 more
    • Blood collection
    • +5 more
    • Kigali, Rwanda
      Rwanda Military Hospital
    Feb 9, 2022

    Human Immunodeficiency Virus, Stigma, Social, Patient Engagement Trial in New York (A set of implementation strategies to reduce

    Enrolling by invitation
    • Human Immunodeficiency Virus
    • +2 more
    • A set of implementation strategies to reduce sexual stigma
    • New York, New York
      New York State Psychiatric Institute
    Feb 15, 2022

    Human Immunodeficiency Virus, Smoking Trial in Durham (Bupropion, Varenicline, Cognitive Behavioral Therapy)

    Completed
    Has Results
    • Human Immunodeficiency Virus
    • Smoking
    • Durham, North Carolina
      Durham VA Medical Center, Durham, NC
    Jan 26, 2022

    Human Immunodeficiency Virus Trial in Boston, New York (3BNC117, 10-1074, Analytical treatment interruption)

    Completed
    • Human Immunodeficiency Virus
    • Boston, Massachusetts
    • +1 more
    Feb 11, 2022

    Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS)

    Completed
    • Human Immunodeficiency Virus
    • New York, New York
    • +2 more
    Feb 11, 2022

    Malignant Tumors of Mesothelial and Soft Tissue, Human Immunodeficiency Virus Trial in Houston (behavioral, device, procedure)

    Completed
    • Malignant Neoplasms of Mesothelial and Soft Tissue
    • Human Immunodeficiency Virus
    • Screening Interview
    • +5 more
    • Houston, Texas
      Bering Omega/Houston Area Community Services
    Feb 10, 2022